A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...

Background: Atrial fibrillation (AF) is one of the most prevalent arrhythmias and is characterized by a high risk of heart failure and embolic stroke, yet its underlying mechanism is unclear. The ...

Women with permanent AF have a greater heart failure risk than men, with unique sex-specific risk factors identified. Read ...

The presence of atrial fibrillation promotes the development of atrial thrombus, and consequently increases the risk of stroke five-fold. Vitamin K antagonists, most notable among which is ...

It doesn't make any difference whether you have the paroxysmal form of atrial fibrillation or persistent atrial fibrillation; the risks of thromboembolic complications are similar. So, the ...

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...

Atrial fibrillation (AF) is frequent in patients with rheumatic mitral stenosis (MS). Pressure overload leads to marked structural and electrical remodelling of left atrium. The frequency of ...